de Andrade Mesquita L, Fagundes Piccoli G, Richter da Natividade G, Frison Spiazzi B, Colpani V, Gerchman F
In a recent study, Tan and coworkers engineered and expressed two GLP-1 analogues by genetically fusing a modified GLP-1 (Ala8Gly) to one or two tandem HSA-binding DARPins through a (GGGGS) 3 flexible linker
In vitro models for the bloodbrain barrier
This is a powdered liposomal technology used to improve the release and bioavailability of water-soluble and readily oxidisable substances such as glutathione
Patients with complex medical histories, unexplained symptoms, pregnancy considerations, immune disorders, active cancer concerns, severe allergies, medication interactions, or competitive sport obligations should avoid self-directed use and seek medical guidance